Benefits and safety of landiolol for rapid rate control in patients with atrial tachyarrhythmias and acute decompensated heart failure. | Eur Heart J Suppl;24(Suppl D): D11-D21, 2022 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Benefits and safety of landiolol for rapid rate control in patients with atrial tachyarrhythmias and acute decompensated heart failure.

Shiga, Tsuyoshi.

Affiliation

Shiga T; Department of Clinical Pharmacology and Therapeutics, The Jikei University School of Medicine, Tokyo, Japan.

Eur Heart J Suppl ; 24(Suppl D): D11-D21, 2022 Jun.

Article in En | MEDLINE | ID: mdl-35706898

Key words

Atrial fibrillation; Beta blockers; Heart failure; Landiolol; Rate control

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Eur Heart J Suppl Year: 2022 Document type: Article Affiliation country: Japan Country of publication: United kingdom

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Eur Heart J Suppl Year: 2022 Document type: Article Affiliation country: Japan Country of publication: United kingdom